Genesis IBRC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194N01016
  • NSEID:
  • BSEID: 514336
INR
111.20
-5.85 (-5.0%)
BSENSE

Dec 05

BSE+NSE Vol: 144

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Smruthi Organic
Sotac Pharma.
Quest Laborato.
Genesis IBRC
Auro Labs.
Panch.Organics
Coral Labs.
Alpa Laboratorie
Pharmaids Pharma
Balaxi Pharma
Astonea Labs
Why is Genesis IBRC India Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.64
  • The company has been able to generate a Return on Equity (avg) of 9.30% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
  • NO KEY NEGATIVE TRIGGERS
3
With ROE of 41.9, it has a Very Expensive valuation with a 18.2 Price to Book Value
  • Over the past year, while the stock has generated a return of 568.27%, its profits have fallen by 0%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Genesis IBRC for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Genesis IBRC
568.27%
10.86
52.32%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-1.03%
ROE (avg)
9.30%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
43
Industry P/E
38
Price to Book Value
18.22
EV to EBIT
43.33
EV to EBITDA
43.33
EV to Capital Employed
18.39
EV to Sales
41.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
42.44%
ROE (Latest)
41.92%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...